Moxetumomab Pasudotox Pivotal in relapse refractory hairy cell leukemia

Editor

7 years ago

Michelle Dawson, MD, AstraZeneca, talks about Moxetumomab Pasudotox Pivotal in relapse refractory hairy cell leukemia at Annual Meeting 2018.